|
Compositions acting as (pro)renin receptor antagonists for the treatment of non-alcoholic fatty liver disease
BackgroundNon-alcoholic fatty liver disease (NAFLD) is an umbrella term for a range of liver conditions where excess fat is stored in the liver, and affects people with little to no alcohol use. Non-alcoholic steatohepatitis (NASH) is a potentially serious form of the disease that includes liver inflammation and potential scarring, cirrhosis, and liver...
Published: 4/23/2020
|
Updated: 12/10/2019
|
Inventor(s): Yumei Earley
Keywords(s):
Category(s): Healthcare & Pharmaceuticals, Chemical
|
